Clinical Trial Detail

NCT ID NCT03971799
Title Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Center for International Blood and Marrow Transplant Research
Indications

acute myeloid leukemia

Therapies

Cyclophosphamide + Fludarabine

Anti-CD33 CART cells

Age Groups: adult child

No variant requirements are available.